Netherlands· NL-86c1cc219b47

Acebutolol Aurobindo 400 mg, filmomhulde tabletten

A acebutolol product containing acebutololhydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC C07AB04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about acebutololhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Acebutolol is registered in 10 of 19 countries.

Countries holding a registration under ATC C07AB04 (acebutolol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search acebutolol products by name

Acebutolol · ATC C07AB04

10 / 19 countries

Belgiumprice
Canada
Czechiaprice
Finlandprice
Franceprice
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acebutolol costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Acebutolol · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

FR France$0.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ACEBUTOLOLHYDROCHLORIDE
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: C07AB04
ATC class: Acebutolol
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
120319

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

295 interactions on record for acebutolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check acebutolol against other medicines How interaction checks work

Acebutolol · interactions on record

295 records

11 severe
184 moderate
21 minor
79 info

Most severe, free to view

DolasetronA04AA04severe
TheophyllinC01EB28severe
CeritinibL01ED02severe
CeritinibL01XE28severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acebutolol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acebutolol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

Czechia · Acecor, Sectral
France · Acebutolol Almus, Acebutolol Arrow Lab
United Kingdom (Northern Ireland) · Acebutolol Milpharm, Sectral
Italy · Sectral
Poland · Acebutolol Gedeon Richter, Acecor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/def4c503-0dc9-4d54-b316-939615b6d346
GET /v1/drugs/def4c503-0dc9-4d54-b316-939615b6d346?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120319_smpc.pdf",
  "strength": null,
  "atc_label": "Acebutolol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120319",
  "excipients": [
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ACEBUTOLOLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120319.pdf",
  "authorised_at": "2018/05/03",
  "procedure_number": "NL/H/4727/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120319",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about acebutolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console